Back to Search
HAYMAR HANN, MD
MD
Internal Medicine Physician
NPI: 1558944587IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
332375(NY)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2013
Research & Publications (20)
Syndecan-2 regulates the migratory potential of melanoma cells.
PMID 19641225·J Biol Chem·2009
7-preclinical
Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.
PMID 19065670·Hepatology·2009
3-trial
A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B : Lamivudine resistance.
PMID 19669319·Hepatol Int·2008
8-other
Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV).
PMID 19669311·Hepatol Int·2008
8-other
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B.
PMID 18363895·Aliment Pharmacol Ther·2008
3-trial
Active antiviral therapy for chronic hepatitis B and hepatocellular carcinoma.
PMID 18299665·Minerva Gastroenterol Dietol·2008
6-review
Symptomatology and health attitudes of chronic hepatitis B patients in the USA.
PMID 18088244·J Viral Hepat·2008
8-other
Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3.
PMID 17787016·J Neurosci Res·2008
7-preclinical
Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection.
PMID 18472982·Ther Clin Risk Manag·2007
8-other
Baseline HBV DNA level is the most important factor associated with virologic breakthrough in chronic hepatitis B treated with lamivudine.
PMID 17696226·World J Gastroenterol·2007
4-observational
Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations.
PMID 17690322·Radiology·2007
8-other
Hepatitis B virus infection in 6,130 unvaccinated Korean-Americans surveyed between 1988 and 1990.
PMID 17397407·Am J Gastroenterol·2007
8-other
Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.
PMID 16457596·J Proteome Res·2006
8-other
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.
PMID 16083710·Gastroenterology·2005
3-trial
Comparison of evidence-based therapeutic intervention between community- and hospital-based primary care clinics.
PMID 16033623·Int J Clin Pract·2005
4-observational
Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B.
PMID 15740489·J Gastroenterol Hepatol·2005
4-observational
Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
PMID 15492253·Cancer Res·2004
8-other
Influence of maternal serum levels of vitamins C and E during the second trimester on birth weight and length.
PMID 15054416·Eur J Clin Nutr·2004
8-other
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.
PMID 14699490·Gastroenterology·2004
3-trial
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
PMID 12514773·Liver Transpl·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 630 PINEBROOK BLVD
NEW ROCHELLE, NY 10804 - Phone
- (914) 327-1038
Quick Facts
- NPI
- 1558944587
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile